Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01041157
NCT01041157
Unknown
Phase 1

Effectiveness of Botulinum Toxin Injection After Exercising Splenius Capitis Muscle in Patients With Cervical Dystonia

Jyväskylä Central Hospital1 site in 1 country22 target enrollmentSeptember 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTorticollisMuscle Spasticity

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Torticollis
Sponsor
Jyväskylä Central Hospital
Enrollment
22
Locations
1
Primary Endpoint
Muscle tone in splenius capitis muscle
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of the study is to examine the effect of the botulinum toxin injection into muscle tone, strength and mobility with and without muscle exercise effect.

Detailed Description

The purpose is also to find out patients subjective symptoms between injections. Hypothesis: Efficiency of the botulinum toxin is more powerful with the muscle exercise before injection.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
December 2011
Last Updated
16 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Jyväskylä Central Hospital

Eligibility Criteria

Inclusion Criteria

  • •Clinical diagnosis of cervical dystonia
  • •Spasticity in splenius capitis muscle
  • •Regular treatment with botulinum toxin injection

Exclusion Criteria

  • •Don't want to take part the Trial
  • •Very long distance from home to Jyväskylä Central Hospital

Outcomes

Primary Outcomes

Muscle tone in splenius capitis muscle

Time Frame: five months

Secondary Outcomes

  • Neck muscle strength(five months)
  • Mobility in the neck(five months)
  • Pain in the neck(five months)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a StrokePost-stroke Spasticity of the Lower Limb
NCT01464307Merz Pharmaceuticals GmbH290
Completed
Phase 3
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a StrokePost-stroke Spasticity of the Upper Limb
NCT01392300Merz Pharmaceuticals GmbH317
Terminated
Phase 4
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's DiseaseParkinson Disease
NCT00477802University of Cincinnati8
Completed
Phase 4
The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower ExtremitiesChronic PainLower Extremity Wound
NCT05426161Bispebjerg Hospital10
Unknown
N/A
Effects of Botulinum Toxin Injection on Sensation and Postural Control in Children With Hemiplegic Cerebral PalsyCerebral PalsyHemiplegic Cerebral Palsy
NCT04940143Marmara University19